Similar articles

• HL-A-identical marrow transplants in aplastic anemia, acute leukemia, and lymphosarcoma employing cyclophosphamide.

  Santos GW, Sensenbrenner LL, Anderson PN, Burke PJ, Klein DL, Slavin RE, Schacter B, Borgaonkar DS. Santos GW, et al. Transplant Proc. 1976 Dec;8(4):607-10. Transplant Proc. 1976. PMID: 11591 No abstract available.
• Marrow transplants in aplastic anemia and leukemia.

  Fefer A, Thomas ED, Buckner CD, Storb R, Neiman P, Glucksberg H, Clift RA, Lerner KG. Fefer A, et al. Semin Hematol. 1974 Jul;11(3):353-67. Semin Hematol. 1974. PMID: 4151983 Review. No abstract available.
• Marrow grafting in patients with acute leukemia.

  Thomas ED, Buckner CD, Clift RA, Fass L, Fefer A, Lerner KG, Neiman P, Rowley N, Storb R. Thomas ED, et al. Transplant Proc. 1973 Mar;5(1):917-22. Transplant Proc. 1973. PMID: 4144473 No abstract available.
• Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors.

  Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED. Glucksberg H, et al. Transplantation. 1974 Oct;18(4):295-304. doi: 10.1097/00007890-197410000-00001. Transplantation. 1974. PMID: 4153799 No abstract available.
• Allogeneic marrow transplantation using matched sibling donors.

  Thomas ED. Thomas ED. Transplant Proc. 1974 Dec;6(4 Suppl 1):115-9. Transplant Proc. 1974. PMID: 4155158 Review. No abstract available.